The global Targeted RNA Sequencing market size was valued at US$ 2772 million in 2024 and is forecast to a readjusted size of USD 10970 million by 2031 with a CAGR of 22.0% during review period.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
麻豆原创 competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
This report is a detailed and comprehensive analysis for global Targeted RNA Sequencing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted RNA Sequencing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Targeted RNA Sequencing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Targeted RNA Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Targeted RNA Sequencing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted RNA Sequencing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted RNA Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Targeted RNA Sequencing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
麻豆原创 segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
麻豆原创 segment by players, this report covers
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted RNA Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted RNA Sequencing, with revenue, gross margin, and global market share of Targeted RNA Sequencing from 2020 to 2025.
Chapter 3, the Targeted RNA Sequencing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Targeted RNA Sequencing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted RNA Sequencing.
Chapter 13, to describe Targeted RNA Sequencing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Targeted RNA Sequencing by Type
1.3.1 Overview: Global Targeted RNA Sequencing 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Targeted RNA Sequencing Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Exome Sequencing
1.3.4 Enrichment Sequencing
1.3.5 Amplicon Sequencing
1.4 Global Targeted RNA Sequencing 麻豆原创 by Application
1.4.1 Overview: Global Targeted RNA Sequencing 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Research Institutes
1.4.3 Hospitals & Clinics
1.4.4 Biotechnology Company
1.4.5 Diagnostic Lab
1.5 Global Targeted RNA Sequencing 麻豆原创 Size & Forecast
1.6 Global Targeted RNA Sequencing 麻豆原创 Size and Forecast by Region
1.6.1 Global Targeted RNA Sequencing 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Targeted RNA Sequencing 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Targeted RNA Sequencing 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Targeted RNA Sequencing 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Targeted RNA Sequencing 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Targeted RNA Sequencing 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Targeted RNA Sequencing 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Targeted RNA Sequencing Product and Solutions
2.1.4 Thermo Fisher Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Targeted RNA Sequencing Product and Solutions
2.2.4 Illumina Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Illumina Recent Developments and Future Plans
2.3 Roche Holdings
2.3.1 Roche Holdings Details
2.3.2 Roche Holdings Major Business
2.3.3 Roche Holdings Targeted RNA Sequencing Product and Solutions
2.3.4 Roche Holdings Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Roche Holdings Recent Developments and Future Plans
2.4 BGI
2.4.1 BGI Details
2.4.2 BGI Major Business
2.4.3 BGI Targeted RNA Sequencing Product and Solutions
2.4.4 BGI Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 BGI Recent Developments and Future Plans
2.5 Eurofins
2.5.1 Eurofins Details
2.5.2 Eurofins Major Business
2.5.3 Eurofins Targeted RNA Sequencing Product and Solutions
2.5.4 Eurofins Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Eurofins Recent Developments and Future Plans
2.6 LabCorp
2.6.1 LabCorp Details
2.6.2 LabCorp Major Business
2.6.3 LabCorp Targeted RNA Sequencing Product and Solutions
2.6.4 LabCorp Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 LabCorp Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics Targeted RNA Sequencing Product and Solutions
2.7.4 Berry Genomics Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Macrogen
2.8.1 Macrogen Details
2.8.2 Macrogen Major Business
2.8.3 Macrogen Targeted RNA Sequencing Product and Solutions
2.8.4 Macrogen Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Macrogen Recent Developments and Future Plans
2.9 GENEWIZ
2.9.1 GENEWIZ Details
2.9.2 GENEWIZ Major Business
2.9.3 GENEWIZ Targeted RNA Sequencing Product and Solutions
2.9.4 GENEWIZ Targeted RNA Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 GENEWIZ Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Targeted RNA Sequencing Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Targeted RNA Sequencing by Company Revenue
3.2.2 Top 3 Targeted RNA Sequencing Players 麻豆原创 Share in 2024
3.2.3 Top 6 Targeted RNA Sequencing Players 麻豆原创 Share in 2024
3.3 Targeted RNA Sequencing 麻豆原创: Overall Company Footprint Analysis
3.3.1 Targeted RNA Sequencing 麻豆原创: Region Footprint
3.3.2 Targeted RNA Sequencing 麻豆原创: Company Product Type Footprint
3.3.3 Targeted RNA Sequencing 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Targeted RNA Sequencing Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Targeted RNA Sequencing 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Targeted RNA Sequencing Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Targeted RNA Sequencing 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Targeted RNA Sequencing Consumption Value by Type (2020-2031)
6.2 North America Targeted RNA Sequencing 麻豆原创 Size by Application (2020-2031)
6.3 North America Targeted RNA Sequencing 麻豆原创 Size by Country
6.3.1 North America Targeted RNA Sequencing Consumption Value by Country (2020-2031)
6.3.2 United States Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Targeted RNA Sequencing Consumption Value by Type (2020-2031)
7.2 Europe Targeted RNA Sequencing Consumption Value by Application (2020-2031)
7.3 Europe Targeted RNA Sequencing 麻豆原创 Size by Country
7.3.1 Europe Targeted RNA Sequencing Consumption Value by Country (2020-2031)
7.3.2 Germany Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Targeted RNA Sequencing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Targeted RNA Sequencing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Targeted RNA Sequencing 麻豆原创 Size by Region
8.3.1 Asia-Pacific Targeted RNA Sequencing Consumption Value by Region (2020-2031)
8.3.2 China Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Targeted RNA Sequencing Consumption Value by Type (2020-2031)
9.2 South America Targeted RNA Sequencing Consumption Value by Application (2020-2031)
9.3 South America Targeted RNA Sequencing 麻豆原创 Size by Country
9.3.1 South America Targeted RNA Sequencing Consumption Value by Country (2020-2031)
9.3.2 Brazil Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Targeted RNA Sequencing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Targeted RNA Sequencing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Targeted RNA Sequencing 麻豆原创 Size by Country
10.3.1 Middle East & Africa Targeted RNA Sequencing Consumption Value by Country (2020-2031)
10.3.2 Turkey Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Targeted RNA Sequencing 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Targeted RNA Sequencing 麻豆原创 Drivers
11.2 Targeted RNA Sequencing 麻豆原创 Restraints
11.3 Targeted RNA Sequencing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Targeted RNA Sequencing Industry Chain
12.2 Targeted RNA Sequencing Upstream Analysis
12.3 Targeted RNA Sequencing Midstream Analysis
12.4 Targeted RNA Sequencing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
听
听
*If Applicable.
